Illumina, Inc. (ILMN) vs Natera, Inc. (NTRA)
- Illumina, Inc. ILMN 211.25 +1.56%
- Natera, Inc. NTRA 309.69 −14.86%
Illumina, Inc. and Natera, Inc. are both Diagnostics & Research companies. Natera, Inc. is the larger, with a market value of $52.4B against $31.5B — 1.7× the size. Natera, Inc. has negative trailing earnings, so its P/E is not meaningful; Illumina, Inc. trades at 35.6×. Natera, Inc. grew revenue faster over the last twelve months: 37.4% against 5.83%. Illumina, Inc. has the higher net margin (19.7% vs −5.66%) and the higher return on invested capital (16.7% vs −8.35%). Across the 20 metrics below, Illumina, Inc. leads on 16 and Natera, Inc. on 4.
Valuation
Profitability
| Metric | ILMN | NTRA | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 67.87% | 0.00% | 48.32% |
| Operating margin | 21.18% | (8.95%) | (5.68%) |
| Net margin | 19.72% | (5.66%) | (4.10%) |
| Free cash flow margin | 23.29% | 1.80% | 0.00% |
| Return on equity | 32.39% | (10.55%) | 0.00% |
| Return on assets | 13.78% | (7.21%) | (6.05%) |
| Return on invested capital | 16.70% | (8.35%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack